Finance

Beta
Lists
BETRF:OTCMKTS
BetterLife Pharma Inc
USD 0,043
-5,79%
(-0,0026) 1D
5 Jun., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BETRF...
Open
USD 0,05
High
USD 0,05
Low
USD 0,04
Mkt. cap
9,01 m
Avg. vol.
32,44 k
Volume
265,40 k
52-wk high
USD 0,08
52-wk low
USD 0,03
Beta
0,47
Shares outstanding
161,79 m
No. of employees
4
Open
USD 0,05
High
USD 0,05
Low
USD 0,04
Mkt. cap
9,01 m
Avg. vol.
32,44 k
Volume
265,40 k
52-wk high
USD 0,08
52-wk low
USD 0,03
Beta
0,47
Shares outstanding
161,79 m
No. of employees
4
News stories
From sources across the web
About BetterLife Pharma Inc
CEO-
Employees4
Founded2002
HeadquartersVancouver, Brits-Columbië, Kanada
SectorPharmaceutical industry
Websiteabetterlifepharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Apr. 2025
Jul. 2025
Okt. 2025
Jan. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
13,62 k
1,58 k
11,98 k
58,50 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
457,12 k
510,05 k
377,24 k
378,51 k
Operating expense
470,75 k
511,63 k
389,22 k
437,01 k
Total operating expenses
470,75 k
511,63 k
389,22 k
437,01 k
Operating income
-470,75 k
-511,63 k
-389,22 k
-437,01 k
Other non operating income
30,74 k
65,27 k
49,60 k
21,21 k
EBT including unusual items
-207,05 k
-504,11 k
-420,13 k
-381,62 k
EBT excluding unusual items
-357,05 k
-504,11 k
-420,13 k
-391,57 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-211,45 k
-494,48 k
-409,01 k
-380,55 k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-77,10 k
-47,58 k
-35,76 k
-71,50 k
Net interest expenses
-77,10 k
-47,58 k
-35,76 k
-71,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer